Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion type Assertion NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_head.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion description "[In vivo, endothelial cell-derived PRL is expected to combine with PRL of tumor cell and pituitary origin to raise the concentration of this polypeptide hormone in the tumor microenvironment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_provenance.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion evidence source_evidence_literature NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_provenance.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion SIO_000772 25472543 NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_provenance.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion wasDerivedFrom befree-2016 NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_provenance.
- NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_assertion wasGeneratedBy ECO_0000203 NP1244571.RArSCU5xDRdgFYLj_DenKu23yIqHp3vkL6K08Qew6YIS8130_provenance.